Page last updated: 2024-08-25

hp 873 and Weight Gain

hp 873 has been researched along with Weight Gain in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Asamoah, AL; Gosal, R; Grossberg, GT; Nair, A; Salem, A1
Ballon, JS; Contreras, I; Freyberg, R; Freyberg, Z; Leibel, RL; Lieberman, JA; Mayer, LE; Pajvani, UB; Rosenbaum, M1
Lavedan, C; Thompson, A; Volpi, S1
Citrome, L1
Correll, CU; De Hert, M; Detraux, J; Sweers, K; van Winkel, R; Yu, W1
Cutler, AJ; Polymeropoulos, MH; Weiden, PJ; Wolfgang, CD1

Reviews

4 review(s) available for hp 873 and Weight Gain

ArticleYear
An update on the efficacy and safety of iloperidone as a schizophrenia therapy.
    Expert opinion on pharmacotherapy, 2020, Volume: 21, Issue:15

    Topics: Antipsychotic Agents; Humans; Isoxazoles; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D2; Schizophrenia; Weight Gain

2020
Iloperidone: a clinical overview.
    The Journal of clinical psychiatry, 2011, Volume: 72 Suppl 1

    Topics: Antipsychotic Agents; Electrocardiography; Heart Rate; Humans; Isoxazoles; Long QT Syndrome; Piperidines; Schizophrenia; Treatment Outcome; Weight Gain

2011
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.
    CNS drugs, 2012, Sep-01, Volume: 26, Issue:9

    Topics: Antipsychotic Agents; Bipolar Disorder; Blood Glucose; Dibenzocycloheptenes; Heterocyclic Compounds, 4 or More Rings; Humans; Isoindoles; Isoxazoles; Lipid Metabolism; Lurasidone Hydrochloride; Paliperidone Palmitate; Piperidines; Pyrimidines; Randomized Controlled Trials as Topic; Schizophrenia; Thiazoles; Weight Gain

2012
Safety profile of iloperidone: a pooled analysis of 6-week acute-phase pivotal trials.
    Journal of clinical psychopharmacology, 2008, Volume: 28, Issue:2 Suppl 1

    Topics: Adolescent; Adult; Aged; Akathisia, Drug-Induced; Antipsychotic Agents; Basal Ganglia Diseases; Double-Blind Method; Female; Humans; Isoxazoles; Long QT Syndrome; Male; Middle Aged; Patient Dropouts; Piperidines; Prospective Studies; Psychotic Disorders; Randomized Controlled Trials as Topic; Schizophrenia; Weight Gain

2008

Trials

2 trial(s) available for hp 873 and Weight Gain

ArticleYear
Pathophysiology of drug induced weight and metabolic effects: findings from an RCT in healthy volunteers treated with olanzapine, iloperidone, or placebo.
    Journal of psychopharmacology (Oxford, England), 2018, Volume: 32, Issue:5

    Topics: Adolescent; Adult; Antipsychotic Agents; Blood Glucose; Body Weight; Double-Blind Method; Dyslipidemias; Eating; Energy Metabolism; Female; Glucose Tolerance Test; Healthy Volunteers; Humans; Insulin; Insulin Resistance; Isoxazoles; Lipids; Male; Obesity; Olanzapine; Piperidines; Weight Gain; Young Adult

2018
Absence of weight gain association with the HTR2C -759C/T polymorphism in patients with schizophrenia treated with iloperidone.
    Psychiatry research, 2010, Feb-28, Volume: 175, Issue:3

    Topics: Analysis of Variance; Antipsychotic Agents; Female; Follow-Up Studies; Gene Frequency; Genotype; Humans; Isoxazoles; Male; Piperazines; Piperidines; Polymorphism, Genetic; Receptor, Serotonin, 5-HT2C; Schizophrenia; Thiazoles; Weight Gain

2010